“Early stage investing in biotechnology not for the weak of heart; nevertheless, it is a truly rewarding experience to work with scientific entrepreneurs and management to develop therapies that would make meaningful contributions to patients’ lives.”

Sundar Kodiyalam


Mr. Kodiyalam serves as a Senior Advisor to Accelerator and Board Director to ALSP Orchid Acquisition Corporation I (NASDAQ: ALORU | ALOR).  Prior to his role at Accelerator, Mr. Kodiyalam co-founded Vatera Healthcare Partners, a family office venture capital firm focused on healthcare, where he served as its Managing Director for more than 10 years. Prior to his role at Vatera Healthcare Partners, Mr. Kodiyalam served as Senior Vice President of Commercial Development & New Business Ventures at Kos Pharmaceuticals, Inc., which was later acquired by Abbott Laboratories, now Abbvie Pharmaceuticals (NYSE: ABBV). Prior to his role at Kos Pharmaceuticals, Mr. Kodiyalam served as Vice President of Commercial Development at Ortec International, Director of Business Development & Licensing at Schering-Plough Corporation, and in various domestic and international marketing roles at Novartis Pharmaceuticals Corporation.

Mr. Kodiyalam received his B. Pharm in Pharmacy from Madras University (India) and his M.S. in Pharmaceutical Administration from Ohio State University. Mr. Kodiyalam currently serves on several private biotech and nonprofit organization boards.